Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,862 | -7,097 | -10,811 | -13,218 | -13,343 |
| Depreciation Amortization | 33 | 52 | 39 | 19 | 5 |
| Income taxes - deferred | 12 | 95 | 86 | -1,342 | N/A |
| Accounts payable and accrued liabilities | 137 | 147 | -642 | -706 | 713 |
| Other Working Capital | -321 | -2,719 | -1,033 | 7,111 | 4,414 |
| Other Operating Activity | -316 | 1,368 | 1,518 | 1,667 | -202 |
| Operating Cash Flow | $-7,317 | $-8,154 | $-10,845 | $-6,469 | $-8,413 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | -20 | -37 | -11 |
| Net Acquisitions | -111 | N/A | N/A | N/A | 186 |
| Other Investing Activity | -114 | 0 | -250 | 0 | 0 |
| Investing Cash Flow | $-244 | $N/A | $-270 | $-37 | $175 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 278 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -5 | -10 | -13 | -3 |
| Common Stock Issued | 5,218 | 2,150 | 1,206 | 54 | 3,769 |
| Other Financing Activity | -499 | 1,775 | 10,109 | 10,630 | -268 |
| Financing Cash Flow | $4,998 | $3,921 | $11,305 | $10,671 | $3,498 |
| Exchange Rate Effect | -27 | 6 | 8 | 5 | 6 |
| Beginning Cash Position | 3,822 | 8,049 | 7,851 | 3,680 | 8,414 |
| End Cash Position | 1,231 | 3,822 | 8,049 | 7,851 | 3,680 |
| Net Cash Flow | $-2,591 | $-4,228 | $198 | $4,171 | $-4,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,317 | -8,154 | -10,845 | -6,469 | -8,413 |
| Capital Expenditure | -20 | N/A | -20 | -37 | -11 |
| Free Cash Flow | -7,337 | -8,154 | -10,865 | -6,506 | -8,424 |